Senseonics Holdings, Inc. (SENS)
USD 0.74
(6.36%)
USD 0.74
(6.36%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -27.93 Million USD | -171.88% |
| 2022 | 38.85 Million USD | 30.21% |
| 2021 | 29.84 Million USD | -33.22% |
| 2020 | 44.69 Million USD | 91.91% |
| 2019 | 23.28 Million USD | 127.13% |
| 2018 | -85.82 Million USD | -1129.91% |
| 2017 | 8.33 Million USD | 35.03% |
| 2016 | 6.17 Million USD | 3.73% |
| 2015 | 5.94 Million USD | 165.32% |
| 2014 | -9.1 Million USD | -90980.0% |
| 2013 | -10 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | -8.96 Million USD | -151.36% |
| 2023 Q4 | 24.08 Million USD | 174.18% |
| 2023 Q3 | -32.46 Million USD | -16.21% |
| 2023 FY | -27.93 Million USD | -171.88% |
| 2023 Q2 | -27.93 Million USD | -211.67% |
| 2022 Q1 | 64.83 Million USD | 171.76% |
| 2022 Q2 | 36.16 Million USD | -44.21% |
| 2022 Q3 | -5.03 Million USD | -113.91% |
| 2022 Q4 | 17.44 Million USD | 446.88% |
| 2022 FY | 38.85 Million USD | 30.21% |
| 2021 Q3 | 25.6 Million USD | -16.71% |
| 2021 FY | 29.84 Million USD | -33.22% |
| 2021 Q1 | 17.75 Million USD | 314.48% |
| 2021 Q2 | 30.74 Million USD | 73.17% |
| 2021 Q4 | 23.85 Million USD | -6.84% |
| 2020 Q1 | 35.91 Million USD | -15.35% |
| 2020 Q3 | -118.44 Million USD | -365.05% |
| 2020 Q4 | -8.27 Million USD | 93.01% |
| 2020 FY | 44.69 Million USD | 91.91% |
| 2020 Q2 | 44.69 Million USD | 24.42% |
| 2019 Q3 | 48.48 Million USD | 108.2% |
| 2019 Q2 | 23.28 Million USD | 162.63% |
| 2019 Q1 | -37.18 Million USD | -140.48% |
| 2019 Q4 | 42.43 Million USD | -12.48% |
| 2019 FY | 23.28 Million USD | 127.13% |
| 2018 Q2 | -85.82 Million USD | 17.85% |
| 2018 Q4 | -15.46 Million USD | 70.36% |
| 2018 Q3 | -52.15 Million USD | 39.23% |
| 2018 FY | -85.82 Million USD | -1129.91% |
| 2018 Q1 | -104.46 Million USD | 19.49% |
| 2017 Q1 | -5.37 Million USD | 41.22% |
| 2017 FY | 8.33 Million USD | 35.03% |
| 2017 Q4 | -129.76 Million USD | -2606.3% |
| 2017 Q3 | -4.79 Million USD | -157.54% |
| 2017 Q2 | 8.33 Million USD | 255.0% |
| 2016 Q1 | -1.68 Million USD | 92.2% |
| 2016 FY | 6.17 Million USD | 3.73% |
| 2016 Q4 | -9.14 Million USD | -173.49% |
| 2016 Q3 | 12.44 Million USD | 101.67% |
| 2016 Q2 | 6.17 Million USD | 466.88% |
| 2015 Q1 | 7193.00 USD | 822.19% |
| 2015 Q4 | -21.57 Million USD | 21.45% |
| 2015 Q3 | -27.46 Million USD | -567.02% |
| 2015 Q2 | 5.88 Million USD | 81646.14% |
| 2015 FY | 5.94 Million USD | 165.32% |
| 2014 Q1 | -4419.00 USD | 0.0% |
| 2014 Q3 | -14.72 Thousand USD | -100.15% |
| 2014 Q4 | -996.00 USD | 93.24% |
| 2014 FY | -9.1 Million USD | -90980.0% |
| 2014 Q2 | 9.79 Million USD | 221820.12% |
| 2013 FY | -10 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | -20.99 Million USD | -33.054% |
| Electromed, Inc. | -15.99 Million USD | -74.651% |
| Catheter Precision, Inc. | -3.19 Million USD | -774.789% |
| Xtant Medical Holdings, Inc. | 17.63 Million USD | 258.381% |